CDG Therapeutics, Inc.   Report issue

For profit Phase 1
Founded: Chicago IL United States (2001)
Status: Left NME R&D (2014)

Organization Overview

First Clinical Trial
2009
NCT00914914
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Dr. Tapas K. Das Gupta

Active Ingredients

Drugs in Phase 1 Trials (1)

p28 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1